TEM
Tempus Ai Inc
NASDAQ · Life Sciences Tools & Services
$54.91
+2.47 (+4.71%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.03B | 740.18M | 4.54B | 4.22B | 4.70B |
| Net Income | -1,047,731,366 | -678,094,512 | 621.49M | 751.80M | 807.44M |
| EPS | — | — | — | — | — |
| Profit Margin | -101.8% | -96.7% | 13.7% | 17.8% | 17.2% |
| Rev Growth | +39.1% | +39.1% | +12.8% | +21.7% | +17.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 4.32B | 4.32B | 4.16B | 4.60B | 4.62B |
| Total Equity | 559.57M | 559.57M | 6.44B | 6.78B | 7.47B |
| D/E Ratio | 7.73 | 7.73 | 0.65 | 0.68 | 0.62 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -959,720,650 | -655,641,174 | 1.48B | 1.29B | 1.47B |
| Free Cash Flow | — | — | 362.34M | 351.34M | 441.08M |